CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
about
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice.Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation.Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity.The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain.Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy.Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
P2860
Q33681317-4A2D1A46-8E7C-42EA-A197-A2F4BFC7595EQ36655166-4AD3B4BA-A54B-4CED-8F5B-3BB9B65F815AQ37157298-B6129D78-520A-4D82-92A7-632FCA369DEFQ37592175-567CDFA1-AEA5-43EE-AB5A-E6F286F3C46DQ38600704-27D847F1-9DA4-4C61-8AA5-75BBDECFD879Q38694552-0AB55E36-E15E-4847-A73B-F1DC77FB90ADQ38732473-A1D449D3-2FA8-490C-93E4-664DB313E673Q39141647-BEA41B66-F965-4ED1-B518-501D10D4308DQ42129148-03ECBDB5-5402-4F02-A44B-CA5B1BE500C1Q45068836-D23366E9-A550-40E7-A027-67DF036F8DB0Q47159191-B751C281-2C55-4385-A28C-D98888D5BE16Q47958585-F1B686F7-D316-4164-AC8E-48A548704CEFQ48337573-76070DD3-F6E9-4E9D-B16A-0E01A1BF6CCFQ52655461-D782BA41-5BFA-40E9-9D3E-685DEFD5B169Q57174777-D907F805-A85F-45F2-AF53-9BD3E43A84E6
P2860
CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@ast
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@en
type
label
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@ast
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@en
prefLabel
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@ast
CB1 Knockout Mice Unveil Susta ...... axel-Induced Neuropathic Pain.
@en
P2093
P2860
P356
P1476
CB1 Knockout Mice Unveil Susta ...... taxel-Induced Neuropathic Pain
@en
P2093
Andrea G Hohmann
Benjamin L Cornett
Liting Deng
P2860
P356
10.1124/MOL.115.098483
P50
P577
2015-04-22T00:00:00Z